Fragmentation Studies of Lysine and Lysine Analog Containing Tetrapeptides by Hasan, Zachariah Imran
W&M ScholarWorks 
Undergraduate Honors Theses Theses, Dissertations, & Master Projects 
5-2016 
Fragmentation Studies of Lysine and Lysine Analog Containing 
Tetrapeptides 
Zachariah Imran Hasan 
College of William and Mary 
Follow this and additional works at: https://scholarworks.wm.edu/honorstheses 
 Part of the Analytical Chemistry Commons, Biochemistry, Biophysics, and Structural Biology 
Commons, and the Bioinformatics Commons 
Recommended Citation 
Hasan, Zachariah Imran, "Fragmentation Studies of Lysine and Lysine Analog Containing Tetrapeptides" 
(2016). Undergraduate Honors Theses. Paper 926. 
https://scholarworks.wm.edu/honorstheses/926 
This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at 
W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized 
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu. 

i 
 
Table of Contents 
List of Figures ............................................................................................................................... iii 
Acknowledgements ........................................................................................................................v 
Abstract ......................................................................................................................................... vi 
Chapter 1: Introduction ................................................................................................................1 
1.1 MS-based Proteomics ................................................................................................................1 
1.2 Peptide Fragmentation .............................................................................................................12 
      1.2.1 Fragmentation Mechanisms ............................................................................................12 
      1.2.2 Variations of b ions .........................................................................................................14 
      1.2.3 Selective Cleavages ........................................................................................................18 
      1.2.4 Macrocyclization.............................................................................................................24 
1.3 Tetrapeptide Fragmentation Studies ........................................................................................26 
      1.3.1 Lysine, Ornithine, DABA, DAPA ..................................................................................26 
      1.3.2 Tetrapeptides of Interest .................................................................................................27 
Chapter 2: Experimental Methods .............................................................................................29 
2.1 Peptide Synthesis .....................................................................................................................29 
      2.1.1 Example Synthesis of AAKA .........................................................................................31 
2.2 ESI-Ion Trap Mass Spectrometry ............................................................................................35 
      2.2.1 Sample Preparation .........................................................................................................35 
Chapter 3: Results and Discussion .............................................................................................36 
3.1 Alanine-Alanine-Alanine-X .....................................................................................................36 
      3.1.1 AAAK .............................................................................................................................36 
      3.1.2 AAAO .............................................................................................................................39 
      3.1.3 AAAB .............................................................................................................................41 
      3.1.4 AAAZ .............................................................................................................................42 
3.2 Alanine-Alanine-X-Alanine .....................................................................................................44 
      3.2.1 AAKA .............................................................................................................................44 
      3.2.2 AAOA .............................................................................................................................46 
      3.2.3 AABA .............................................................................................................................47 
      3.2.4 AAZA .............................................................................................................................48 
ii 
 
3.3 Alanine-X-Alanine-Alanine .....................................................................................................50 
      3.3.1 AKAA .............................................................................................................................50 
      3.3.2 AOAA .............................................................................................................................51 
      3.3.3 ABAA .............................................................................................................................53 
      3.3.4 AZAA .............................................................................................................................54 
3.4 X-Alanine-Alanine-Alanine .....................................................................................................55 
      3.4.1 KAAA .............................................................................................................................55 
      3.4.2 OAAA .............................................................................................................................57 
      3.4.3 BAAA .............................................................................................................................58 
      3.4.4 ZAAA .............................................................................................................................59 
3.5 Tyrosine-Alanine-Glycine-X ...................................................................................................60 
      3.5.1 YAGK .............................................................................................................................61 
      3.5.2 YAGO .............................................................................................................................63 
      3.5.3 YAGB .............................................................................................................................64 
      3.5.4 YAGZ .............................................................................................................................65 
3.6 Trends ......................................................................................................................................67 
Chapter 4: Conclusions ...............................................................................................................69 
References .....................................................................................................................................71 
Appendix .......................................................................................................................................76 
 
  
 
 
 
 
 
 
iii 
 
List of Figures 
Figure 1.1 Gel vs. LC-MS based Proteomics  ...................................................................................2 
Figure 1.2 Bottom-up, Middle-down, Top-Down Proteomics ..........................................................4 
Figure 1.3 LC-ESI Apparatus ............................................................................................................8 
Figure 1.4 ESI Schematic ..................................................................................................................9 
Figure 1.5 MS/MS CID Spectrum .....................................................................................................10 
Figure 1.6 Peptide Fragmentation Sites .............................................................................................12 
Figure 1.7 CID vs. ECD or ETD........................................................................................................13 
Figure 1.8 Mobile Proton Mechanism ...............................................................................................14 
Figure 1.9 bx, yz Ion Pathway ............................................................................................................16 
Figure 1.10 bn Ion Variations .............................................................................................................17 
Figure 1.11 Proline Effect ..................................................................................................................19 
Figure 1.12 Histidine Effect ...............................................................................................................20 
Figure 1.13 Glutamine Cleavage .......................................................................................................21 
Figure 1.14 Oxidized Cysteine Cleavage ...........................................................................................21 
Figure 1.15 Lysine and Arginine Effect ............................................................................................22 
Figure 1.16 Ornithine Effect ..............................................................................................................23 
Figure 1.17 YAGFL-NH2 Macrocyclization .....................................................................................25 
Figure 1.18 Lysine, Ornithine, DABA, DAPA ..................................................................................27 
Figure 1.19 Tetrapeptide Macrocycle ................................................................................................28 
Figure 2.1 Fmoc-Lys(Boc)-Wang Resin............................................................................................29 
Figure 2.2 Synthesis of AAKA ..........................................................................................................31 
Figure 2.3 AAAX Tetrapeptides ........................................................................................................33 
Figure 2.4 AAXA Tetrapeptides ........................................................................................................33 
Figure 2.5 AXAA Tetrapeptides ........................................................................................................34 
iv 
 
Figure 2.6 XAAA Tetrapeptides ........................................................................................................34 
Figure 2.7 YAGX Tetrapeptides ........................................................................................................34 
Figure 2.8 ESI-Ion trap Schematic.....................................................................................................35 
Figure 3.1 CID Spectrum of AAAK ..................................................................................................36 
Table 3.1 CID Activation Data AAAX, AAXA, AXAA, XAAA .....................................................38 
Figure 3.2 CID Spectrum of AAAO ..................................................................................................39 
Figure 3.3 CID Spectrum of AAAB ..................................................................................................41 
Figure 3.4 CID Spectrum of AAAZ ..................................................................................................42 
Figure 3.5 CID Spectrum of AAKA ..................................................................................................44 
Figure 3.6 CID Spectrum of AAOA ..................................................................................................46 
Figure 3.7 CID Spectrum of AABA ..................................................................................................47 
Figure 3.8 CID Spectrum of AAZA ..................................................................................................48 
Figure 3.9 CID Spectrum of AKAA ..................................................................................................50 
Figure 3.10 CID Spectrum of AOAA ................................................................................................51 
Figure 3.11 CID Spectrum of ABAA ................................................................................................53 
Figure 3.12 CID Spectrum of AZAA  ...............................................................................................54 
Figure 3.13 CID Spectrum of KAAA ................................................................................................55 
Figure 3.14 CID Spectrum of OAAA ................................................................................................57 
Figure 3.15 CID Spectrum of BAAA ................................................................................................58 
Figure 3.16 CID Spectrum of ZAAA ................................................................................................59 
Figure 3.17 CID Spectrum of YAGK ................................................................................................61 
Table 3.2 CID Activation Data YAGX..............................................................................................62 
Figure 3.18 CID Spectrum of YAGO ................................................................................................63 
Figure 3.19 CID Spectrum of YAGB ................................................................................................64 
Figure 3.20 CID Spectrum of YAGZ ................................................................................................65 
v 
 
Acknowledgements 
 I would like to thank Dr. John C. Poutsma for the opportunity to do research on such an 
interesting topic, his guidance throughout my honors project, and his mentorship in and out of 
the lab. I would like to thank my fellow Ionlab members, especially Hannah Smith, Anton 
Lachowicz, Matthew Wang, and Ethan Jones for their help when needed and for making my 
undergraduate research experience memorable. I would like to thank the W&M Charles Center 
for Honors Fellowship financial support to conduct summer research. Finally, special thanks to 
my friends and family, who have supported me throughout this process.  
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
Abstract 
 The fragmentation patterns of lysine and lysine-analog containing tetrapeptides were 
analyzed in this study using collision induced dissociation (CID) in an ESI-ion trap mass 
spectrometer. Understanding the fragmentation mechanisms of lysine-containing peptides is 
integral to improving bottom-up proteomics techniques and peptide sequencing and searching 
algorithms. Lysine and its non-protein amino acid (NPAA) analogs ornithine, DABA, and 
DAPA have been shown to affect fragmentation patterns based on their basicities in dipeptides 
and tripeptides. Studies have shown the occurrence of sequence scrambling due to 
macrocyclization of pentapeptides during fragmentation, which can result in inaccurate database 
matching. This study of the twenty tetrapeptides AAAX, AAXA, AXAA, XAAA, and YAGX  
(X = Lys, Orn, DABA, or DAPA) looked for macrocyclization leading to sequence scrambling 
and analyzed the effects of positional variance and of differing basicities between lysine and its 
analogs on tetrapeptide fragmentation patterns. 
 Fragmentation studies confirmed the occurrence of the ornithine effect, where there is 
selective cleavage C-terminal to an ornithine residue within the tetrapeptides. Macrocyclic 
sequence scrambling was found to not occur in significant amounts for these tetrapeptides. The 
formation of bn + H2O ions was found to be most prevalent when the basic amino acid residues 
were at the C-terminus of the tetrapeptides. Positional variance and basicities of the lysine and its 
NPAA analogs affected the stabilities of the tetrapeptides, and influenced fragmentation patterns. 
Further investigations of lysine-containing peptides are necessary to better understand the 
fragmentation mechanisms at work and improve the robustness of proteomics experiments using 
mass spectrometry.   
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Chapter 1: Introduction 
 Advances in molecular biology and genetics research leading to the sequencing of the 
human genome have sparked new investigations into understanding the proteomes of humans 
and other organisms [1-4]. Mass spectrometry has become a widely used technique in proteomics 
research for sequencing peptides and proteins [1-51]. Specifically, fragmentation of peptides in 
tandem mass spectrometry allows for mass spectra of peptide fragments to be obtained [1-6, 10-
51]. Ultimately, these peptide mass spectra can be matched to specific proteins in protein 
structural databases, creating a powerful tool for future biochemistry and molecular biology 
research [1-5, 20-27].  Much of current research in mass spectrometric peptide sequencing 
focuses on further understanding of the underlying mechanisms of the peptide fragmentation 
process [1-4, 30-51]. For example, in the peptide fragmentation process, selective cleavages 
based on the chemical properties of amino acid residues in the peptide can occur [2, 30-47]. 
Further understanding of these mechanisms can lead to enhanced accuracy of peptide 
identification, and therefore a more robust proteomics experiment.  
 
1.1 MS-based Proteomics 
 Mass spectrometry based proteomics research utilizes a combination of biochemistry and 
analytical chemistry laboratory techniques. The first step in a proteomics experiment is usually to 
isolate the protein of interest from its source. Proper isolation of the protein at a high level of 
purity is vital to ensuring that the subsequent mass spectrometry experiments are as accurate as 
possible [6]. The protein purification process relies on a variety of laboratory techniques 
including subcellular fractionation, used to break open cells and organelles, and centrifugation, 
used to further separate fractions based on size and density [6]. Specifically, multiple steps of 
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differential centrifugation and density gradient centrifugation techniques are used to obtain 
fractions containing purified proteins [6]. Proteins within a fraction can be separated from one 
another using gel-electrophoresis techniques (most commonly 2D-PAGE) [3-4, 7]. Subsequently, 
the portion of the gel containing the protein of interest can be removed for further analysis [4, 7-
8]. Alternatively, the proteins can be digested and then separated using liquid chromatography 
(LC) techniques such as LC, high performance liquid chromatography (HPLC) or nanoHPLC 
[4]. Finally, the proteins or digests are mass analyzed and fragmented via tandem mass 
spectrometry (MS/MS) and then identified or sequenced via protein databases [1-5, 20-27] 
Figure 1.1 below adapted from Roepstorff, 2012 summarizes these two proteomics strategies.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Summary of gel based proteomics and liquid chromatography coupled proteomics. 
Adapted from [4].  
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 MS-based proteomics research can be divided into profiling, functional, and structural 
proteomics [9-10]. Profiling proteomics aims to profile the proteins present in different samples 
and analyze their similarities and differences [9]. This can be used for a wide variety of 
applications including determining unknown organisms, cells, protein fractions, etc. by 
comparing to known samples, differentiating wild-type vs. mutant proteomes, differentiating 
between healthy and diseased states of cells, quantizing metabolites, etc. [9, 11-13]. Functional 
proteomics examines post-translational modifications, biological protein functions and 
interactions with other molecules [9-10]. Structural proteomics aims to analyze and identify all 
levels of protein structure (primary sequence, secondary structural features, native protein 
folding, protein complexes and subunits) [9].  
 There are three major strategies of MS-based proteomics experiments: top-down, middle-
down and bottom-up proteomics (see Figure 1.2) [3, 5]. In these proteomics experiments, 
identification, molecular characterization, and sequence determination of proteins can be 
assessed based on their fragment ion mass spectra [1-6, 10-51]. In top-down proteomics, intact 
proteins are directly analyzed via tandem mass spectrometry techniques allowing for a variety of 
experiments of profiling, functional and structural proteomics [5, 9]. The main advantage of top 
down proteomics is that it allows for the identification and analysis of post-translational 
modifications (PTM) and PTM hierarchies [5, 14]. For example, Moradian et al. 2013 noted that 
top down proteomics has been successful in analyzing certain PTMs of histones [5]. However, 
the efficacy of top down proteomics is limited by poor protein fractionation and mass spectrum 
resolution (due to the large masses of intact proteins >10kDa), and difficulties in fragmentation 
of large proteins [3, 5, 14]. A top down method is also useful for conducting profiling proteomics 
experiments. More recently, advances in orbitrap mass analyzers and Fourier transform ion 
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cyclotron resonance (FT-ICR) mass spectrometry have increased the viability of top down 
proteomics experiments (increased mass resolution and dynamic range), but widespread 
experimentation via these techniques is still cost prohibitive [5, 15].  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Summary of diagram of bottom up, middle down, and top down proteomics 
techniques. Adapted from [3].  
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 In middle down and bottom up proteomics, the proteins are enzymatically digested prior 
to analysis with MS/MS [1-5, 16]. Middle down proteomics involves restricted protein digestion 
(for example using Glu-C or Asp-N enzymes) to create medium sized peptides (around 2kDa to 
10kDa) [3, 5]. Middle down proteomics is advantageous because it retains some ability to study 
post translational modifications, while reducing the size of the peptides to increase instrumental 
resolution [3, 5]. The ability to analyze PTMs and obtain spectra with a higher resolution than 
top down approaches makes the middle down approach a strong choice for functional proteomics 
experiments [3, 5, 9].  
 
 Of all the forms of proteomics experiments, bottom up or “shotgun” proteomics remains 
widespread for profiling and structural experiments [3-4, 9]. As previously noted, the large size 
and complexity of biological proteins makes direct fragmentation in a mass spectrometer 
difficult [3, 5, 14, 16]. In bottom up proteomics, the protein of interest is enzymatically digested 
using a proteolytic enzyme such as trypsin to create smaller mass peptides (0.5kDa to 3kDa) that 
can more easily be analyzed by various mass spectrometry techniques [1-4, 7, 16-17]. Trypsin is 
most commonly used because of its high cleavage efficiency and high specificity for the C-
terminus of lysine and arginine amino acid residues [16]. Additionally, tryptic digests create 
peptides of, on average, 9-10 amino acids long, which is very conducive to tandem mass 
spectrometric analysis [3, 16, 18]. However, the efficacy of using of trypsin as a proteolytic 
enzyme for bottom up proteomics was studied by Lowenthal, et al. in 2013 [16]. Their research 
suggests that there can be slight variability in the digestion patterns of trypsin, motivating further 
research on the effects of digestion conditions on the kinetics of proteolysis as used for bottom 
up proteomics [16]. Other physical digestion techniques such as microwave heating, acid 
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hydrolysis, and electrochemical oxidation have also been shown as a means of reproducibly 
digesting proteins into peptides of similar lengths to tryptic digests [3, 18-19]. Because of the 
widespread use of trypsin in bottom-up proteomics, analysis of the fragmentation patterns of 
peptides that contain C-terminal lysine or arginine residues are important for ensuring the 
reproducibility and accuracy of bottom-up proteomics protein characterizations.   
 
 High performance liquid chromatography (HPLC) is often used in bottom-up 
experiments to separate the peptides in a tryptic digest from one another before analysis with 
tandem mass spectrometry (MS/MS) [1, 3-5, 7-9]. MS/MS works by further separating the 
digests by selecting analytes of a specific mass, and fragmenting these digest peptides using a 
method such as collision-induced dissociation (CID) to obtain fragment ion spectra [1-5, 10-51]. 
The resulting fragmentation spectra can then be matched to theoretical peptide fragmentation 
spectra using computer searching algorithms such as SEQUEST, Mascot, MS-Fit, ProFound, 
MaxQuant, PEDRo, etc. [20-27]. These programs generate theoretical spectra that using well 
established fragmentation rules [20-27]. Once identified, the peptides can be matched to 
individual proteins by searching against a database containing known primary protein sequences 
[20-27]. Further research on the fundamentals of the peptide fragmentation process can improve 
the theoretical spectrum generation and matching accuracy of databases such as SEQUEST, 
Mascot, etc.  
 High performance liquid chromatography is essential to the bottom-up proteomics 
experiment because of its ability to separate digested peptides from one another before 
introduction into the mass spectrometer [1, 3-10]. This improves the resolution of the MS/MS 
spectra, and increases sequence coverage and sequencing accuracy [9]. HPLC is also 
7 
 
advantageous because it can be used in-line with electrospray ionization (ESI), a soft-ionization 
technique that is the most advantageous ionization source for studying biomolecules [1-5, 8-9, 
16, 28-29]. In addition to HPLC-ESI-MS/MS, techniques such as multidimensional high 
performance liquid chromatography have been developed to achieve an improved separation 
resolution [9].  
 
 In their review paper on HPLC techniques for proteomic analyses, Goran Mitulovic and 
Karl Mechtler stress the importance of multidimensional techniques, optimized flow rate, and 
optimized column stationary phases for a robust HPLC separation [9]. The complexity and sheer 
number of peptides from the enzymatically digested proteins tend to exceed the peak capacity of 
most one-dimensional HPLC columns [9]. For this reason, adopting a multidimensional 
approach by adding additional columns, which will increase peak capacity for the system, proves 
beneficial to applications in proteomics research [9]. Further, the injection volumes and flow 
rates of the HPLC system should be lowered to nano-liter (nL) injection volumes and 200-
300nL/min flow rates for optimized proteomic separation and analysis [9]. If nL sample injection 
volumes are used in the HPLC, nanospray-ESI is the best sample introduction method for the 
subsequent MS/MS [16]. Finally, column stationary phase compositions should be taken into 
consideration when conducting proteomics experiments. Immobilized metal-ion chromatography 
(IMAC) implemented prior to nanoHPLC, while using a titanium dioxide (TiO2) column 
(because of its high affinity to organic phosphates) makes for an excellent peptide separation 
scheme [9].  
 Once the peptides are appropriately separated, they must be introduced into the mass 
spectrometer. In early proteomics research, matrix assisted laser desorption ionization (MALDI) 
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was commonly used for sample introduction after gel-electrophoresis (generally 2D-PAGE) 
separation [9]. The MALDI source is often coupled with a time of flight (TOF) mass analyzer, 
which is capable of mass analyzing large molecular ions (up to approximately 300kDa) [9, 55]. 
The disadvantage of using MALDI-TOF for proteomics experiments is that despite high 
resolution, the peptide introduction is off-line, meaning the peptides must be spotted on a target 
for introduction into the MS [9]. Consequently, the sample preparation process is time 
consuming, and therefore the use of inline HPLC-ESI-MS/MS is a more efficient and appealing 
technique for proteomics researchers (see Figure 1.3). Additionally, ESI is a proven soft 
ionization sample introduction technique for analysis of biomolecules as it causes minimal 
disruption of the native state structures upon ionization [28-29]. ESI works by flowing sample 
solution through a charged capillary tube, creating a spray of charged droplets that undergo 
coulombic explosion and solvent evaporation resulting in molecular ion formation (see Figure 
1.4) [28]. In 1989, John Fenn showed that ESI also can form multiply charged ions, allowing for 
analysis of very large biomolecules with mass spectrometry [28].  
 
 
 
 
 
 
 
Figure 1.3 Example of an LC in line with an ESI source entering a quadrupole mass spectrometer 
(multiple quadrupoles would allow MS/MS). Obtained from [28]. 
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Figure 1.4 Schematic of ESI solvent droplet undergoing coulombic explosion and solvent 
evaporation to produce molecular ions of the analyte. Obtained from 
[http://www.chem.pitt.edu/sites/default/files/figure3.PNG].  
 
 Tandem mass spectrometry (MS/MS) involves the mass selection (various mass 
analyzers can be used) and fragmentation of peptides, creating a mass spectrum of the peptide [1-
5, 10-51]. The fragment ions that are analyzed originate from cleavages along the peptide 
backbone of a peptide [21, 30-47]. A common method of achieving this peptide bond cleavage is 
through collision induced dissociation (CID) activation, a hard-fragmentation technique [30]. In 
the MS/MS experiment, the peptides are separated in a first mass selection stage. Next, inert gas 
is leaked into the instrument and allowed to collide with the molecular (peptide) ions [17]. 
During these collisions, the kinetic energy of the inert gas molecules is converted into internal 
energy within the peptide molecular ions, causing bond breakage and fragmentation of peptides 
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[17]. These fragments can then be mass analyzed to generate a mass spectrum for the peptide 
that can be compared to sequence databases (see Figure 1.5).  
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Example of a MS/MS CID spectrum of the peptide LVEGLANDPENKVPLIK using 
an ion trap mass spectrometer. Obtained from [41].  
 
 In addition to collision induced dissociation, other hard-ionization techniques are 
available for use in tandem mass spectrometry, including surface induced dissociation (SID), 
electron impact (EI), infrared multiphoton dissociation (IRMPD), electron capture dissociation 
(ECD), electron transfer dissociation (ETD) and electron induced dissociation (EID) [31]. SID 
works by colliding ions with a surface to cause dissociation, and is designed to cause higher 
energy ion collisions than CID [32]. As such, SID can be used to probe quaternary structure of 
protein complexes in the gas phase [32]. Mosely et al. noted that ECD was particularly useful for 
identifying functional group modifications within protein samples such as phosphorylation, 
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sulphation, acetylation or glycosylation [31]. EID and ECD produce particularly good data that 
can complement CID data, but using CID produces spectra in a more consistent manner [31]. 
Thus CID would make a slightly better dissociation technique for creating a uniform database of 
fragmented peptide spectra and sequences.  
 
 After fragmentation spectra are obtained, a searching algorithm and database of predicted 
peptide fragmentation spectra and known sequences such as SEQUEST, Mascot, etc. is used to 
identify the experimental sample [20-27]. According to Dong et al., the searching algorithms 
generally incorporate categories of data for predictions, including de novo sequencing, protein 
sequence database searches, sequence tag approaches, and a spectral library search [20]. For 
example, the searching algorithm SEQUEST uses the spectral library search and a protein 
sequence database search [20]. The protein sequence database data is based on predicted peptide 
fragments due to theoretical enzymatic digestion [20]. However, there are many potential 
complications of the peptide fragmentation process that need to be fully studied to ensure 
accurate theoretical spectra for comparison are generated [20, 23]. Using protein sequence 
database matches in combination with spectral data matches likely produces the most accurate 
and robust results [23]. In order to create high accuracy databases, research into the methods of 
enzymatic digestion and into complications in the peptide fragmentation process is vital [1-4, 16, 
23, 30]. 
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1.2 Peptide Fragmentation  
 
1.2.1 Fragmentation Mechanisms 
 Peptide fragmentation pathways in MS/MS are studied to better understand the effects 
amino acid residues within the peptide sequences have on the fragmentation patterns [2, 30-47]. 
When ionized by ESI, singly charged peptides are protonated at the most basic site within the 
peptide, which is usually the N-terminus of the peptide. However, when basic amino acid 
residues such as lysine, arginine, or histidine are present, the peptide will be protonated on the 
side chains of these amino acids. When fragmented, peptides would be expected to show random 
cleavage along multiple sites in the peptide backbone as shown in Figure 1.6 below [30]. In 
actuality, selective cleavages preferentially forming specific product ions have been documented 
extensively in the literature [2, 30-47]. Understanding these fragmentation pathways and their 
mechanisms are critical to improving matching with databases of MS/MS spectra [30].  
 
 
 
 
 
 
Figure 1.6 Potential fragmentation sites along the backbone of a pentapeptide and nomenclature 
of product ions formed. Obtained from [30].   
 
 As seen above in Figure 1.6, fragmentation along the backbone can form product ions 
referred to as a, x, b, y, c, and z ions. The types of product ions that are formed depends on the 
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dissociative technique used [3, 5, 14, 21, 30]. For example, using CID to fragment the peptide 
will result in the formation of y and b ions (with some a ions) [3, 21,30]. Using ECD or ETD to 
fragment the peptides will result in the formation of only c and z ions via different fragmentation 
mechanisms (see Figure 1.7) [3, 5]. When designing a proteomics experiment, the choice of 
which activation technique to use and its resulting fragmentation mechanisms must be carefully 
considered.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 Schematic depicting the differing product ion formation when using CID vs ECD or 
ETD on a pentapeptide. Adapted from [3].  
 
 Under CID conditions, the mobile proton model is the most widely accepted model for 
describing peptide fragmentation mechanisms (see Figure 1.8) [30, 33]. In this model, the proton 
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creating the positive charge on the ionized peptide is mobilized by the applied CID energy, and 
can be relocated at any amine or oxygen site within the peptide (including amino acid side 
chains) [30, 33]. However, the mobility of this proton can be obstructed by basic amino acid 
residues, thus resulting in selective ion formation [30, 33]. In Figure 1.8, an example mobile 
proton mechanism involving the charge-directed nucleophilic attack induced by the proton 
located on the amide oxygen or amide nitrogen is depicted [33]. Protons at these locations would 
result in b and y ion formation under CID fragmentation conditions [33].  
 
 
 
 
 
 
 
 
 
 
Figure 1.8 Mobile proton mechanism depicting formation of b ions (depicted) and corresponding 
y ion (not shown). Adapted from [33].  
 
1.2.2 Variations of b ions 
 Under CID of peptides, b ions are formed in various isomers [30, 34-36]. The mobile 
proton mechanism in Figure 1.8 shows the formation of a linear acylium (right) or an oxazolone 
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derivative (left) b ion [33]. Using infrared multiphoton dissociation (IRMPD) studies it has been 
experimentally shown that b ions will form the more stable oxazolone over the linear acylium 
ion [34]. The mechanism for the bx-yz pathway forming an oxazolone b ion involves nucleophilic 
attack by an oxygen (N-terminal) on the carbonyl carbon of the neighboring (C-terminal) amide 
bond when the mobile proton is on the oxygen of the carbonyl carbon (see Figure 1.9) [30]. 
Alternatively, it has also been shown that cyclic peptide b ions can be formed by nucleophilic 
attack of the N-terminus on the carbonyl carbon of the amide bond where the mobile proton is on 
the carbonyl oxygen (see Figure 1.10).  [30, 34]. In the case of b2 ion formation a 
diketopiperazine structure is formed, and can be protonated via proton transfer from the y ion 
(Figure 1.11) [30].  
 
 The formation of diketopiperazine b ions over oxazolone b ions has been suggested to be 
governed by the length of the peptide chain and the identities of the first three amino acid 
residues [37]. There is also evidence in the literature that a mixture of the two structures can be 
formed with histidine containing peptides (this was noted during IRMPD studies of histidine-
alaninex b2 ions and CID studies) [36, 38-39]. Computational modeling has shown that the side 
chains of arginine and lysine containing peptides can stabilize oxazolone b ion structures via 
intramolecular hydrogen bonding [40]. However, this modeling also showed that the most stable 
arginine b ion was a cyclic peptide structure (the energies of oxazolone and cyclic peptide 
structures for lysine were fairly similar) [40]. Finally, hydrogen deuterium exchange (HDX) 
experiments on doubly protonated tryptic peptides with lysine or arginine at the C terminus 
showed that the protonated oxazolone b ions were preferentially formed over other cyclic peptide 
b ions [35]. 
16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 Mobile proton mechanism of bx-yz pathway forming oxazolone derivative b ion and y 
ion formation. The ion-neutral complex can dissociate and the proton can transfer to either the b 
or y ion. Adapted from [30].  
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Figure 1.10 Mobile proton mechanism of b2 ion diketopiperazine formation (left) and cyclic 
peptide bx ion formation (right) via N-terminus nucleophilic attack. The ion-neutral complexes 
can dissociate and the proton can transfer to either the b or y ion. Adapted from [30]. 
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1.2.3 Selective Cleavages 
 
 There are many reports of selective cleavage effects of amino acid residues throughout 
the literature [1-4, 30-47]. An important selective cleavage that has been noted by multiple 
researchers is the proline effect [2, 30, 41-43]. The proline effect involves an energetic 
preference for N-terminal cleavage of proline residues within the peptide during fragmentation 
forming y ions [2, 41-42]. While the mechanism of the proline effect is still being studied, it is 
believed that the dissociation occurs in a two-step process involving the amide bond cleavage 
and proton transfer, and decomposition of the intermediate to form a y ion fragment (see Figure 
1.11) [2].   
 
 The proline effect is believed to be partially attributed to the ring structure of proline and 
the increased basicity of the prolyl-amide site within the proline containing peptide [2].  The 
proline effect was also found to be influenced by the adjacent N-terminal residue, where the 
effect was strongly observed for Val, His, Asp, Ile, and Leu, while there was a decrease in effect 
with adjacent Gly or Pro [41]. In addition to the proline effect, a more marked selective cleavage 
was observed for pipecolic acid, a six membered ring analog of proline [2]. This pipecolic acid 
effect results in C-terminal cleavage of the peptide bond, and forms b ions [2]. The pipecolic acid 
effect is believed to not be governed by the basicity of the residue, but instead is likely dependent 
on the increased flexibility of the ring structure as compared to proline [2]. 
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Figure 1.11 Proposed mechanism by Raulfs et al. for b and y ion formation based on the proline 
effect Obtained from [2]. 
 
 The histidine effect involves preferential cleavage at the C-terminal side of the histidine 
residue, and is mediated by the protonated histidine side chain [30, 33]. Histidine has a high 
proton affinity (PA) and is therefore likely to be protonated in the gas phase [30]. The histidine 
effect also produces a unique bicyclic b ion fragment (see Figure 1.12) [30]. Similarly, doubly 
protonated peptides containing histidine showed a C-terminal preferential cleavage resulting in 
the same b ion formation [30, 44]. Finally, Huang et al. in 2002 found cleavage at an aspartic 
acid residue was enhanced by a peptide that contained internal basic residues such as histidine 
[45]. They determined an order of basicity for amino acids as arginine (highest) > lysine > 
histidine (lowest) correlates to a higher degree of cleavage at the aspartic acid residue [45].  
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Figure 1.12 Mechanism for the histidine effect and formation of a novel bicyclic b ion. Obtained 
from [30].  
 
 There is evidence for glutamine (Gln) and asparagine (Asn) selective cleavage of the 
amide bond C-terminal to the amino acid residues [30]. These cleavage effects result in the 
formation of another novel b ion in the form of a cyclic isoimide (see Figure 1.13) [30]. A 
cysteine effect has also been shown to cause preferential C-terminal cleavage [46]. Additionally, 
selective C-terminal cleavages of oxidized cysteine residues (Cys-SO2H and Cys-SO3H) require 
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less energy to fragment than unmodified cysteine, providing a means of identifying and locating 
oxidized cysteine residues within peptides (see Figure 1.14) [46].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13 Mechanism of cyclic isoimide b ion formation with a Gln residue. Obtained from 
[30].  
 
 
 
Figure 1.14 Mechanism of oxidized cysteine (Cys-SO2H) preferential C-terminal cleavage. 
Obtained from [46].  
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 There are also interesting fragmentation pathways involving arginine and lysine side 
chains [30]. The side chain amino group of lysine can attack the C-terminal adjacent carbonyl of 
the peptide bond causing C-terminal cleavage [30]. A novel b ion in the form of a protonated 7 
membered caprolactam derivative is formed in this cleavage (see Figure 1.15) [30]. This form 
was proposed because no loss of CO was found in MS/MS/MS studies of b ions from Lys 
containing peptides (an oxazolone would lose CO) [30]. Arginine residues also induce C-
terminal cleavage via nucleophilic attack of the Arg side chain guanidine group [30]. The 
resulting b ions form in a six membered ring as shown in Figure 1.15 [30]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15 Mechanism for cleavage via Lys side chain to form caprolactam derivative b ion 
(left) and mechanism for cleavage via Arg side chain to form six membered ring b ion (right). 
Obtained from [30].  
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 The ornithine effect involves preferential C-terminal cleavage of the amide bond in 
peptide fragmentation [47]. Similar to lysine cleavage, the ornithine side chain amino group acts 
as a nucleophile and attacks the adjacent amide bond carbonyl carbon to form a 6 membered 
lactam ring b ion (Figure 1.16) [47]. This preferential cleavage is even seen with the ornithine 
residue at the C-terminus of the peptide, forming a b ion and loss of H2O as a y ion [47]. McGee 
and McLuckey noted that the ornithine effect is more energetically favored than proline selective 
cleavages [47].  
 
 
 
 
 
 
 
 
 
Figure 1.16 Mechanism of the ornithine effect showing nucleophilic attack of the ornithine side 
chain to create a 6 membered lactam derivative b ion. Obtained from [47].  
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1.2.4 Macrocyclization  
 
 It has been determined that peptide primary sequence scrambling can occur during CID 
of peptides in tandem mass spectrometry [48-50]. As the peptides are activated via CID, 
nucleophilic attack of the N-terminus on a carbonyl carbon at the C-terminus can result in a 
protonated macrocyclic intermediate [48-50]. This macrocyclic intermediate can then cleave at 
any amide bond location within the backbone, resulting in a new peptide with a scrambled 
sequence from the original [48-50]. For example, the pentapeptide YAGFL-NH2 was studied and 
sequence scrambling was observed in the MS/MS spectrum [48-49]. The proposed mechanism 
for this scrambling first involves the formation of the largest possible b ion oxazolone fragment 
(YAGFLoxa), then nucleophilic attack by the N-terminus nitrogen on the oxazolone carbonyl 
group to form a protonated macrocycle (see Figure 1.17) [48-49]. The ring of this protonated 
macrocyclic intermediate of YAGFLoxa can then open via proton transfer, and scramble into any 
of the sequences AGFLYoxa, GFLYAoxa, FLYAGoxa, LYAGFoxa, or YAGFLoxa [48-49].  
 
 All of the above findings of selective peptide fragmentation and macrocyclic 
rearrangements are important to understand so that sequencing databases can accurately predict 
theoretical fragmentation spectra. The lysine and ornithine effects on selective cleavage and 
macrocyclization are of particular relevance to this thesis. Additionally, two other lysine analogs 
will be studied and analyzed for similar selective cleavage effects (see Section 1.3). With 
repeated research on selective cleavage in the fragmentation process, mechanisms can be 
accurately incorporated into peptide spectral and sequencing databases. 
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Figure 1.17: Proposed mechanism for macrocycle formation and primary sequence scrambling of 
the peptide YAGFL-NH2. Obtained from [48]. 
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1.3 Tetrapeptide Fragmentation Studies 
 
1.3.1 Lysine, Ornithine, DABA, and DAPA 
 
 Lysine (lys or K) and its analogs ornithine (orn or O), 2,4-diaminobutanoic acid (DABA 
or B) acid and 2,3-diaminopropanoic acid (DAPA or Z) are the amino acid residues studied in 
this tetrapeptide fragmentation experimentation (see Figure 1.18). Note these amino acids all 
differ by the number of carbons in their respective side chains. Lysine is the amino acid residue 
of this set that is biologically encoded for in humans (protein amino acids or PAAs). Its analogs 
ornithine, DABA, and DAPA are not encoded by the human genome and are described as non-
protein amino acids or NPAAs. Studying the fragmentation patterns of peptides containing lysine 
analogs may provide insight into the fragmentation mechanisms of lysine containing peptides.  
 
 The proton affinities (which can be used to obtain gas-phase basicity) of lysine and its 
NPAA analogs obtained using the extended kinetic method are 1004.2 ± 8.0 , 1001.1 ± 6.6 , 
975.8 ± 7.3, and 950.2 ± 7.1 kJ/mol for lysine, ornithine, DABA, and DAPA, respectively [51]. 
The differing proton affinities will affect the fragmentation patterns of peptides containing these 
residues. The characteristics of the NPAA fragmentation patterns can give greater insights into 
gas phase peptide fragmentation and the characteristics of lysine containing peptide 
fragmentation. Studying the mechanisms of peptide fragmentation containing these species can 
improve peptide sequencing databases and the robustness of a bottom up proteomics experiment 
involving a tryptic digest.   
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Figure 1.18 Lysine and its NPAA analogs Ornithine, DABA, and DAPA 
 
1.3.2 Tetrapeptides of Interest 
 
 Previous Ionlab work has looked at lysine and lysine analog containing dipeptides and 
tripeptides. For this thesis tetrapeptides containing Lysine and its NPAA analogs were 
synthesized and studied via MS/MS CID studies in an ESI- Ion trap mass spectrometer. The 
goals of this study were to confirm the selective cleavage effects of ornithine and lysine in 
tetrapeptides, determine if similar effects for DABA or DAPA are present, and to search for 
potential macrocyclization mediated peptide sequence scrambling in tetrapeptides.  
 
 The first set of peptides analyzed were the set of 16 tetrapeptides AAAX, AAXA, AXAA 
and XAAA where A is alanine and X represents lysine, ornithine, DABA or DAPA. Alanine was 
chosen as the “filler” amino acid to complete the tetrapeptide because of its small size, non-polar 
and neutral side chain, and cost effectiveness. The next set of 4 peptides studied was YAGK, 
YAGO, and YAGB and YAGZ. These were chosen because they are similar tetrapeptide 
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versions of the pentapeptides in the CID fragmentation studies that showed the occurrence of 
macrocyclization [48]. Below is a proposed macrocyclic structure of a tetrapeptide (XAAA) 
showing the potential sequence scrambling based ring opening at any of the 4 peptide amide 
bonds (Figure 1.19).  
 
 
 
Figure 1.19 Proposed macrocyclic intermediate structure example for the XAAA peptide. 
Cleavage at three of the four peptide bonds in the macrocycle would result in sequence 
scrambling to AXAA, AAXA, or AAAX. 
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Chapter 2: Experimental Methods 
2.1 Peptide Synthesis 
 Peptide synthesis was conducted using the Fmoc solid phase peptide synthesis (SPPS) 
method. SPPS uses an insoluble support resin to anchor an amino acid that can be systematically 
added upon, creating a peptide chain [52-54]. The resin is covalently bound to the C-terminus of 
this first amino acid residue, and thus peptides are assembled from C to N terminus. The Fmoc 
SPPS strategy has been shown to effectively synthesize peptide chains of up to 50 amino acids in 
length [52-54]. In our syntheses, a Wang resin (4-Benzyloxybenzyl alcohol, polystyrene polymer 
bound) was used as a solid support (see Figure 2.1). In SPPS, the Fmoc (9-
fluorenylmethoxycarbonyl) is used as a protecting group on the chemically reactive N-terminus 
of the amino acids [52-54]. Additionally, reactive amino acid side chains are protected using Boc 
(t-butyloxycarbonyl), t-butyl (tBu) groups, or a variety of other organic molecules [52].  
 
 
 
 
 
Figure 2.1 Fmoc-Lys(Boc)-Wang resin showing the Lys C terminus bound to the Wang resin, 
Fmoc protecting group on the Lys N terminus, and Boc protecting group on the Lys side chain. 
Obtained from [http://www.matrix-innovation.com/wp-content/uploads/2013/08/Fmoc-L-
LysBoc-Wang-resin.png].  
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 Our Fmoc SPPS strategy begins by adding a pre-loaded amino acid bound Wang resin 
(such as shown in Figure 2.1) into a 12mL plastic syringe with a guard that only allows liquids to 
permeate out of the nozzle. Next, a 50:50 dichloromethane (DCM): N,N-dimethylformamide 
(DMF) solution is used to swell the Wang resin in order to increase resin loading capacity and 
amino acid accessibility. The Fmoc protecting group is then removed via two 20:80 
Piperidine:DMF solution wash steps. The Fmoc is removed from the synthesis syringe using a 
series of DCM and DMF wash steps. Next, an Fmoc protected amino acid (Fmoc-amino acid-
OH) to be added to the peptide chain is dissolved in DMF with the coupling reagents HCTU (2-
(6-Chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate) and DIEA 
(N,N-diisopropylethylamine), which are used to increase the rate of peptide bond formation. The 
HCTU (electron withdrawing group) activates the C-terminus carboxyl group of the added Fmoc 
amino acid for nucleophilic attack by the unprotected N terminus of the amino acid bound to the 
Wang resin resulting in peptide bond formation (and loss of H2O) [52]. The DIEA promotes the 
synthesis to proceed with no racemization [52].  Finally, any unreacted reactants are washed out 
of the syringe via a series of DMF and DCM washes. The above process is repeated until the 
desired peptide chain is synthesized.  
 After synthesis, the peptide must be deprotected and removed from the Wang resin. This 
is accomplished using a series of 20:80 Piperidine:DMF wash steps to remove Fmoc, and a 95% 
trifluoroacetic acid (TFA), 2.5% triisopropylsilane (TIS), and 2.5% H2O solution to cleave the 
peptide from the Wang resin. The cleavage solution will also remove any side chain protecting 
groups on the peptide. The cleaved solution is then diluted with anhydrous diethyl ether, to 
promote peptide precipitation. Finally, the precipitated peptides are centrifuged to remove 
solvent, and allowed to air dry to obtain a solid peptide sample.  
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2.1.1 Example synthesis of Alanine-Alanine-Lysine-Alanine (AAKA) 
 An example synthesis of the tetrapeptide AAKA using the Fmoc SPPS method will be 
described below. Fmoc protected amino acids, Wang resins, and HCTU were purchased from 
ChemPep. Piperidine, TFA, DIEA, and triisopropylsilane were purchased from Sigma-Aldrich. 
Anhydrous diethyl ether, DCM and DMF were purchased from Fischer Scientific. 
Approximately 5mL of solution was used for each wash step, and was conducted for the denoted 
time on a Vortex-Genie 2 shaker. The syringe nozzles were capped with NMR tube cap septums 
during the shaking process. This procedure, outlined in Figure 2.2 below, was used for synthesis 
of all 20 tetrapeptides in this study.  
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Example synthesis summary of AAKA.  
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 First, 0.2g of Fmoc-Ala-Wang resin was added to a 12mL syringe. The resin was then 
swelled for 30 minutes using a 50:50 DCM:DMF solution followed by two 1 min 5mL DMF 
wash steps. Fmoc deprotection was accomplished via one 5 min and a subsequent 30 min wash 
steps with 5mL of 20:80 Piperidine:DMF. Two 1min DMF washes, four 1min DCM washes, and 
two 1 min DMF washes removed the Fmoc protecting group and prepared the resin for addition 
of the next amino acid. Next, a solution of Fmoc-Lys(Boc)-OH (amount dependent on Ala-Wang 
resin loading capacity) with HCTU and DIEA dissolved in DMF was added to the syringe and 
shaken for 1 hour. Subsequently, two 1 min DMF steps and four 1 min DCM wash steps 
removed excess unreacted reagents. This process of conducting Fmoc-Ala-OH additions was 
repeated twice, creating a Fmoc-AAK(Boc)A-Wang protected tetrapeptide.  
 The Fmoc-AAK(Boc)A-Wang was swelled with 50:50 DCM:DMF and deprotected with 
20:80 Piperidine:DMF as outlined above. Next, two 1 min DMF wash steps and four 1 min DCM 
wash steps were conducted. The syringes were then dried with suction. A 10mL cleavage 
solution of 95% trifluoroacetic acid (TFA), 2.5% triisopropylsilane, and 2.5% H2O was added to 
the syringe and placed on the shaker for 2 hours. Finally, the contents of the syringe, with the 
peptide now in solution, were injected into a 100mL round bottom flask and 30mL of cold 
anhydrous diethyl ether was added (giving a total volume of 40mL). This flask was capped and 
stored in the freezer for 24-48 hours to allow for precipitation of the solid peptide.  
 Centrifugation was used to remove the precipitated peptides from the 40mL of ether 
solution. Previous centrifugation techniques used in the lab group called for forty 3 minute runs 
centrifuging 1mL at a time in an epindorf tube to remove all ether and obtain the solid peptide. I 
adjusted the procedure by centrifuging 10mL at a time in larger test tubes (4 times) for 5 
minutes, then taking 2-4 mL of the ether decant to break up the pellet at the base of the test tube. 
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Finally 2-4 1mL 2 min centrifuge runs were used to transfer the peptide to an epindorf tube. This 
resulted in no noticeable loss of product, but saved over 90 minutes of centrifuge time per 
tetrapeptide. After air drying, the peptides were stored in the freezer to prevent degradation.  
 The tetrapeptides AAAK, AAAO, AAAB, AAAZ, AAKA, AAOA, AABA, AAZA, 
AKAA, AOAA, ABAA, AZAA, KAAA, OAAA, BAAA, ZAAA, YAGK, YAGO, YAGB, and 
YAGZ were synthesized (see Figures 2.3-2.7).  
 
 
 
 
 
Figure 2.3 Tetrapeptides AAAK, AAAO, AAAB, and AAAZ 
 
 
 
 
 
 
Figure 2.4 Tetrapeptides AAKA, AAOA, AABA, and AAZA 
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Figure 2.5 Tetrapeptides AKAA, AOAA, ABAA, and AZAA 
 
 
 
 
 
Figure 2.6 Tetrapeptides KAAA, OAAA, BAAA, and ZAAA 
 
 
 
 
 
 
Figure 2.7 Tetrapeptides YAGK, YAGO, YAGB, YAGZ 
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2.2 ESI-Ion Trap Mass Spectrometry 
 Fragmentation studies of the 20 synthesized peptides were carried out in a Thermo LCQ 
Deca quadrupole ion trap mass spectrometer with an ESI sample introduction source (see Figure 
2.8). Parent ion masses of the tetrapeptides were selected using the ion trap successfully with an 
isolation width of 3 m/z. MS/MS studies were conducted in the ion trap using CID with He gas 
to obtain tetrapeptide fragmentation mass spectra. Activation (Q) was set to 0.250, and activation 
time was 30ms for all runs. Data was collected at 0, 20, 25, 28, 30, 32, and 34 % CID. 
Additionally, an activation parameter scan (parent ion count vs. 0-100% CID) was conducted for 
each tetrapeptide. In some instances, product ions of the MS/MS fragmentation were isolated and 
fragmented with CID (MS/MS/MS).  
 
 
 
 
Figure 2.8 ESI ion trap mass spectrometer setup. Obtained from [55]. 
2.2.1 Sample Preparation and Runs 
 Tetrapeptide samples were prepared for MS/MS analysis by dissolving weighed amounts 
of solid peptide in 50:50 MeOH:H2O solution. Various dilutions were performed to obtain 
solutions on the order of approximately 1x10-5M. The peptide solutions were protonated with the 
addition of 1% formic acid solution. Sample introduction into the ESI source was through a 
500μL Hamilton gastight syringe at a flow rate of 12μL/min. Flush runs of 49.5% MeOH: 49.5% 
H2O: 1% formic acid solution were conducted before and after each tetrapeptide run. 
36 
 
Chapter 3: Results and Discussion  
 The CID fragmentation spectra of the 20 synthesized tetrapeptides are presented and 
discussed below. Major product ion peaks have been identified and labeled on the spectra. For 
each of the tetrapeptides studies, an activation parameter scan (CID 0% - 100%) was conducted 
and data for % CID vs. parent normalized ion count was obtained (see Table 3.1 and 3.2). 
Graphs of these activation parameter scans are provided in the Appendix.  
3.1 Alanine-Alanine-Alanine-X 
3.1.1 AAAK 
 
 
 
 
 
 
 
 
Figure 3.1 AAAK MS/MS Spectrum 30% CID 
 Figure 3.1 shows the MS/MS spectrum at 30% CID of AAAK with a parent mass, M+H, 
of 360. The base peak after fragmentation is the y2 ion at m/z of 218. The formation of a b4 ion at 
342 represents a loss of water from the parent mass. The b4 ion can subsequently lose NH3 from 
37 
 
the lysine side chain giving a peak at 325. For AAAK, formation of yn ions seems preferential to 
formation of bn or an ions based off of the relative intensities of product ions. There also is 
significant a3 -NH3 formation at a m/z of 169. This a3 -NH3 ion is present for all AAAX and most 
AXAA (section 3.3) tetrapeptides, but is less commonly found in the fragmentation of AAXA 
(section 3.2) and XAAA (section 3.4) tetrapeptides.  
 Histerodt et al. 2008 found in a study of 200 dipeptides that CID fragmentation could 
yield b ions plus water when there was a basic PAA residue (Lys, Arg or His) at the N terminus 
of the dipeptide [56]. Based on the fragmentation, this would also form an intense y – H2O 
complementary ion to the b + H2O [56]. They noted that b + H2O was not formed in significant 
amounts for any of the other dipeptide combinations [56]. The fragmentation spectrum of AAAK 
shows significant formation of b3+ H2O at a m/z of 232 and corresponding y1 – H2O ion at a m/z 
of 129. This suggests that for tetrapeptides b + H2O formation is not limited to having a basic 
amino acid residue at the N terminus.  This trend of b + H2O ion formation is also observed for 
AAAO (section 3.1.2), YAGK (section 3.5.1), YAGO (section 3.5.2) and KAAA (section 3.4.1). 
Finally, the fact that the intensity of y1 – H2O product is greater than the b3 + H2O product for 
AAAK indicates that proton transfer preferentially favors the y ion upon peptide cleavage by this 
mechanism. This is likely due to the high proton affinity and gas phase basicity of lysine [51].   
 Macrocyclization is likely not occurring for AAAK. There are peaks on the spectrum that 
could represent macrocyclization, but the potential cyclized sequence product ions are isobaric 
with common peaks in the fragmentation spectrum. For example, a m/z of 200 could represent a 
macrocyclized scrambled b2 product peak for KAAA or AKAA. But a m/z of 200 can also be the 
y2 – H2O of AAAK, which is the same ion as a b2 from KAAA or AKAA. Therefore there is no 
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possibility of telling these two structures apart, and the presence of macrocyclization in AAAK 
cannot be supported.  
 AAAK had the second largest amount of CID (42%) required to fragment to 50 percent 
of initial ion count as compared to the other AAAX tetrapeptides (see Table 3.1 below). This is 
because there is the potential for intramolecular stabilization via hydrogen bonding between the 
lysine side chain and an oxygen or nitrogen atom in the peptide, which increases the overall 
stability of AAAK. To further probe the thermodynamics of AAAK, computational modeling 
with methods such as density functional theory calculations will be performed (outside the scope 
of this project). 
 
Tetrapeptide % CID 
AAAK 42% 
AAAO 35% 
AAAB 48% 
AAAZ 33% 
AAKA 37% 
AAOA 34% 
AABA 33% 
AAZA 31% 
AKAA 37% 
AOAA 31% 
ABAA 33% 
AZAA 32% 
KAAA 37% 
OAAA 31% 
BAAA 35% 
ZAAA 33% 
 
Table 3.1 Approximate % CID required to fragment each peptide to 50 percent of parent ion 
count for AAAX, AAXA, AXAA, and XAAA tetrapeptides (see Appendix for graphs).  
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3.1.2 AAAO 
 
 
 
 
 
 
 
 
Figure 3.2 AAAO MS/MS Spectrum 30% CID 
 The base peak for the fragmentation of AAAO (M+H = 346) is b4 ion formation (loss of 
H2O) at a m/z of 328. The b4 ion can lose water to form the peak at a m/z of 310, and 
subsequently lose NH3 to form a product peak at a m/z of 293. The loss of NH3 from the b4 ion is 
observed for AAAK and AAAO, but not AAAB or AAAZ. This indicates that the NH3 is lost 
from the side chain of lysine or ornithine (not the N-terminus of the peptide) and that the b4-NH3 
formation is governed by the basicity of the amino acid residue at the C-terminus (DABA and 
DAPA lower basicity than lysine and ornithine). The intensities of bn and an product ion 
formation are greater than yn ion formation, which is opposite from the observed trend for 
AAAK. The b4 ion formation is indicative of the ornithine effect: preferential C-terminal 
cleavage, in this case to lose water after ornithine side chain attack on the C-terminus forming a 
stable 6 membered lactam ring b4 ion. While the ornithine effect does predominate, there are still 
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a large number of other product ions formed when ornithine is at the C-terminus as compared to 
the CID spectra of AAOA, AOAA, and OAAA.  
 A significant b3 + H2O peak at a m/z of 232 was observed indicating that b + H2O ions 
can be obtained with ornithine at the C-terminus of a tetrapeptide. The study by Histerodt et al. 
2008 did not look at NPAAs, however this finding for AAAO is further evidence that b + H2O 
ions can be formed with a basic amino acid residue which is not located at the N-terminus. This 
effect is likely apparent for ornithine (in AAAO) as well as lysine (in AAAK) because of their 
similar basicities [51].  
 Additionally, there is a3- NH3 formation that is common to all AAAX and most AXAA 
tetrapeptides. The a3 ion consists of two alanine residues and one ornithine (or lysine, DABA, 
DAPA for other AAAX peptides) residue at the C-terminus. It seems that loss of NH3 from an an 
ion could be preferential when the basic amino acid residue is at the C-terminus. Although it is 
still present in AAXA and XAAA tetrapeptides, it is less universal to all the tetrapeptides within 
each set.  
 Similar to AAAK, there is no direct evidence for macrocyclization of AAAO. There are 
peaks in the fragmentation spectrum of AAAO that correspond to sequence scrambled 
fragments, but they cannot be differentiated with CID studies. For example, the b3+ H2O peak at 
a m/z of 232 is also the y3 peak for OAAA (again, these are the same ion). Finally, AAAO 
required the second least amount of % CID (%35) to fragment 50 percent of parent ion count 
(see Table 3.1). This could be because the ornithine effect is energetically favorable. Further 
studies with density functional theory calculations are recommended to assess AAAO 
thermodynamics.  
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3.1.3 AAAB 
 
 
 
 
 
 
 
Figure 3.3 AAAB MS/MS Spectrum 30% CID 
 Similar to AAAO, the base peak for AAAB (M+H = 332) fragmentation is the b4 ion at a 
m/z of 314. This b4 ion can subsequently lose H2O to form a peak at a m/z of 296, but at a 
significantly smaller quantity than observed for AAAK or AAAO. No loss of NH3 from the b4 
ion is observed. This suggests that the side chain length and/or basicity of Lys, Orn, DABA and 
DAPA plays a role in the ability for the tetrapeptide b4 ions to lose H2O or NH3. There is a peak 
at a m/z of 232 present that represents b3 + H2O, but it is very low intensity because of DABA’s 
low basicity. There is also a strong y2- H2O peak, which would suggest a b2+ H2O peak should 
be present at a m/z of 161. Because a peak at a m/z of 161 is not observed, there is preferential 
proton transfer to the y2- H2O fragment due to the proton affinity of DABA (relative to alanine). 
An a3-NH3 fragment is also observed at a m/z of 169. Also, there are fewer fragment peaks 
observed for AAAB than for AAAO or AAAK. 
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 Macrocyclization is not significant for AAAB. However, the peak at a m/z of 172 could 
represent the scrambled b2 of BAAA or ABAA or y2 – H2O, which are the same ion and cannot 
be differentiated.  AAAB surprisingly required the highest CID energy (48%) to fragment to 50 
percent of parent mass of the AAAX tetrapeptides (see Table 3.1). This indicates that the AAAB 
tetrapeptide stability, due to hydrogen bonding between the DABA side chain and oxygen or 
nitrogen on the peptide, is greater than that of AAAK. This increased stability could be because 
the side chain length of DABA is the optimal length and has the optimal orientation for hydrogen 
bonding. HDX experiments, which will be performed in the future, could elucidate this AAAB 
tetrapeptide hydrogen bonding stability. To further probe the energetics of AAAB, density 
functional theory computations are needed.  
3.1.4 AAAZ 
  
 
 
 
 
 
 
Figure 3.4 AAAZ MS/MS Spectrum 30% CID 
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 The base peak for AAAZ (M+H = 318) is the b4 ion at a m/z of 300. There is evidence of 
loss of H2O to form a b4-H2O ion at a m/z of 282, but at a low relative intensity. Of the AAAX 
peptides, AAAZ shows no b + H2O peak formation because DAPA has the lowest basicity as 
compared to lysine, ornithine, and DABA. However, there is a peak at a m/z of 158 that would 
indicate y2- H2O formation, and thus a complementary b + H2O ion could be formed, but proton 
transfer favors the y2- H2O formation due to DABA’s basicity. Additionally, an a3-NH3 product 
ion at a m/z of 169 is observed.  
 There is no significant evidence for macrocyclization in AAAZ. Again there is a peak at a 
m/z of 158 that could represent the scrambled b2 of ZAAA or AZAA or y2 – H2O, but they are 
the same ion. AAAZ shows fewer fragments formed as compared to AAAK and AAAO, but it 
required the least amount of CID to fragment to 50 percent of parent ion count at %33 CID (see 
Table 3.1).  This suggests strong preferential formation of the b4 ion, which is fairly stable. To 
further probe the energetics of AAAZ, density functional theory computations are planned. 
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3.2 Alanine-Alanine-X-Alanine 
3.2.1 AAKA 
 
 
 
 
 
 
 
 
Figure 3.5 AAKA MS/MS Spectrum 30% CID 
 The base peak for the fragmentation of AAKA (M+H = 360), is a K monomer internal 
fragment at a m/z of 129. The formation of monomeric internal fragments in AAXA and AXAA 
is observed at high relative abundances for lysine and ornithine containing tetrapeptides, at much 
lower relative abundances for DABA containing tetrapeptides, and is not observed for DAPA 
containing tetrapeptides. AAKA shows significant b4 formation and loss of NH3 and H2O from 
b4 to form peaks at a m/z of 325 or 324 (NH3 is more intense). This is in contrast to what was 
observed for the AAAX peptides. AAKA may show the formation of bn + H2O, but it is difficult 
to tell because, for example, b3 + H2O shares a peak at a m/z of 289 with the AAKA y3 ion (they 
are the same).  
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 The so called “lysine effect” which hypothesized preferential cleavage C-terminus to 
lysine residues may be present for AAKA. There is significant b3 ion formation for AAKA at a 
m/z of 271 (likely forming a stable caprolactam derivative b ion), but it is only at about 33% 
relative abundance to the base peak. Additionally, this peak can also represent y3-H2O (which is 
the same ion). The strong intensity of K monomer formation could indicate lysine is causing 
preferential C-terminal cleavage, but is not preferentially forming a b ion (cleavage at the both 
peptide bonds surrounding the lysine residue is occurring to form protonated K monomer 
instead).  
 Macrocyclization is not significant for AAKA. There are no peaks present which could 
be interpreted as a product ion of a scrambled sequence. AAKA requires approximately 37% 
CID to fragment to 50 percent of parent ion count, which is the largest of the AAXA 
tetrapeptides. Additionally, the AAXA tetrapeptides follow the trend AAKA> AAOA > AABA 
> AAZA showing a decreasing amount of CID required to fragment as the mass of the parent 
peptide decreases (see Table 3.1). To further probe the energetics of AAKA, density functional 
theory computations are planned. 
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3.2.2 AAOA 
 
 
 
 
 
 
 
Figure 3.6 AAOA MS/MS Spectrum 30% CID 
 CID fragmentation of AAOA (M+H = 342) shows a base peak at a m/z of 257 which is 
the b3 ion. This is confirmation of the ornithine effect showing C-terminal preferential cleavage 
after an ornithine residue. There is the formation of b3 + H2O, but not in significant amounts. The 
b4 and b3 ions can both lose H2O and NH3, but subsequent loss to form a (b-H2O) – NH3 ion is 
not observed. This in contrast to the AAAO tetrapeptide, which had b4 – H2O and (b4 – H2O) – 
NH3 peaks. There is also evidence of an ornithine monomer at a m/z of 115. However, this peak 
could also represent an a2 ion. This peak could be further analyzed with a technique such as 
IRMPD to determine its composition, or if both species are present, their relative abundances 
[36, 38].  
 There is no significant evidence of macrocyclization present for AAOA. The peak at a 
m/z of 186 could be the y2- H2O ion or could represent the scrambled sequence b2 of AOAA or 
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OAAA, which are the same ion. However, based on the intensity of the peak, the formation of 
this ion would not be a significant detriment to peptide sequencing databases. AAOA follows the 
trend of AAKA > AAOA> AABA > AAZA in terms of percent CID required to fragment the 
peptide to 50 percent of parent ion peak requiring 34% CID (see Table 3.1). The energetics of 
AAOA will be further explored using computational studies.  
3.2.3 AABA 
 
 
 
 
 
 
 
Figure 3.7 AABA MS/MS Spectrum 30% CID 
 The base peak in the fragmentation spectrum of AABA (M+H = 332) is the b4 ion. There 
is also a significant amount of parent (M+H) – NH3 present. This strong b4 ion formation (which 
is also noted for AAZA in section 3.2.4 below) was not observed in AAKA or AAOA. DABA 
and DAPA are less basic than Lys or Orn, which affects the energetics of water leaving from the 
C-terminus to form a b4 ion.  Surprisingly, the b4 ion does not lose H2O or NH3 in any significant 
amount. Similarly, this trend is noticed for AAZA below (section 3.2.4). This suggests that the 
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lys and lys NPAA analog side chain lengths and position in the tetrapeptides plays a significant 
role in the loss of NH3 from b ions. There is little evidence for b3 + H2O ion formation in this 
spectrum; however the y3 peak at a m/z of 261 is isobaric with b3 + H2O. Finally, there is almost 
no an ion formation 
 There is no significant evidence for macrocyclization in AABA. AABA required 33% 
CID to fragment to obtain 50 percent of parent ion count, which is lower than that of AAKA and 
AAOA (see Table 3.1). Studying the energetics of AABA using computational calculations may 
provide insight into the reasons for strong b4 ion formation in AABA as opposed to what is 
observed for AAKA or AAOA. 
 
3.2.4 AAZA 
 
 
 
 
 
 
 
Figure 3.8 AAZA MS/MS Spectrum 30% CID 
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 The base peak in the spectrum for AAZA (M+H = 318) is the b4 ion at a m/z of 300. This 
peak is significantly more intense than any other peak in the spectrum. There is a y2 product ion 
at an m/z of 176 has a relative abundance of roughly 8% compared to b4, and a b3 product ion at 
an m/z of 229 which has a relative abundance of about 3% compared to b4. There is likely no 
formation of b + H2O ions. There is a peak at a m/z of 247 that could be either b3 + H2O or a y3 
peak. However, its low intensity compared to the base peak would make it irrelevant for peptide 
sequencing databases. There is almost no an ion formation.  
 There is no significant evidence for macrocyclization in AAZA. The AAZA tetrapeptide 
does not form many fragments as compared to the others in the AAXA set.  AAZA requires the 
least amount (31%) of CID to fragment to 50 percent of parent ion count. This is in keeping with 
the trend noted for the AAXA peptides where AAKA>AAOA>AABA>AAZA for amount of 
CID required to fragment to 50 percent of parent ion count (see Table 3.1). Having a DAPA 
residue in the middle of a tetrapeptide results in a low number of fragment ions being formed 
(also see AZAA in section 3.3.4).  Computational studies on the energetics of AAZA may help 
to elucidate why this trend occurs.  
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3.3 Alanine-X-Alanine-Alanine 
3.3.1 AKAA 
 
 
 
 
 
 
 
 
Figure 3.9 AKAA MS/MS Spectrum 30% CID 
 The base peak for fragmentation of AKAA (M+H = 360) is a b2 ion at a m/z of 200. 
Based on the fragmentation pathways presented by Paizs and Suhai, this b2 ion is likely a 7 
membered caprolactam ring derivative formed from a lysine effect [30]. There is loss of NH3 
from the b4 ion, but no indication of loss of H2O. There is a significant amount of K monomer 
formation for AKAA at a m/z of 129. This further indicates a preference for K monomer 
formation when the lysine residue is in the middle of the tetrapeptide (AKAA and AAKA). In 
contrast to the AAXA peptides, there is significant formation of an ions for AKAA. Loss of NH3 
from the an ions of AKAA is prevalent, which is not unusual seeing as the a ion fragment 
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contains the lysine side chain (likely the site of NH3 loss). There is some indication of b3 + H2O 
formation at an m/z of 298, but this peak is isobaric with AKAA y2 ion.  
 There is little evidence for macrocyclization in the fragmentation spectrum of AKAA. 
The peak at an m/z of 129 which is most likely a K monomer could also be the b1 of KAAA. The 
AKAA tetrapeptide required approximately 37% CID to fragment to 50 percent of the parent ion 
count (see Table 3.1). The energetics of AKAA will be further studied using computational 
methods.  
 
3.3.2 AOAA 
 
 
 
 
 
 
 
 
Figure 3.10 AOAA MS/MS Spectrum 30% CID 
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 The base peak of the fragmentation spectrum for AOAA (M+H = 346) is the b2 ion at a 
m/z of 186. This peak is indicative of the ornithine effect causing selective C-terminal cleavage 
via nucleophilic attack of the ornithine side chain on the adjacent carbonyl group to form the b2 
ion in AOAA. Therefore, this b2 ion contains a 6 membered lactam derivative at its C-terminus. 
The b4 ion loses NH3 but does not lose H2O.   There is no y ion formation for AOAA. There is 
possibly b + H2O ion formation, but at insignificant intensities.  There is formation of an a2- NH3 
(at a m/z of 141) which is found in the AKAA and ABAA spectra as well. There is a significant 
formation of an O monomer at an m/z of 115 (similar to monomer formation found in AKAA, 
AAKA and AAOA) indicating that monomer formation is preferred when the residue in middle 
of the tetrapeptide is lysine or ornithine as opposed to DABA or DAPA.  
 There is no significant evidence for macrocyclization in AOAA. AAOA required 
approximately 31% CID to fragment to 50 percent of parent ion count (see Table 3.1). With a 
similar trend as the AAAX set of tetrapeptides, this is less than the amount required to fragment 
ABAA and AKAA but more than that of AZAA. This lower % CID required may be due to the 
energetic preference of the ornithine effect occurring to form a b2 ion in AOAA. To further probe 
the energetics of AOAA, computational studies will be performed. 
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3.3.3 ABAA 
 
 
 
 
 
 
 
Figure 3.11 ABAA MS/MS Spectrum 30% CID 
 The base peak in the fragmentation spectrum for ABAA (M+H = 332) is the b4 ion at a 
m/z of 314. There is a peak at 297 indicating b4 – NH3 but no loss of H2O is observed. 
Additionally, there is an intense peak at an m/z of 172 which is the formation of a b2 ion. It is 
possible that this b2 ion represents a selective cleavage indicative of a “DABA effect.” This 
would entail the DABA side chain attack of the adjacent c-terminal carbonyl to form a 5 
membered lactam derivative b ion. However, this effect is not as intense for AABA, and 
nonexistent for BAAA (see section 3.4.3).  It is clear that the DABA residue influences 
fragmentation intensities as opposed to random cleavage, potentially based on its location in the 
tetrapeptide chain. There is some indication of b3 + H2O formation at an m/z of 261, but this 
peak is isobaric with ABAA y2 ion. There is no significant evidence for macrocyclization in 
ABAA. ABAA required approximately 33% CID to fragment to 50 percent of parent ion count, 
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which is higher than that of AOAA (see Table 3.1). The energetics of ABAA could be further 
studied with computational studies 
3.3.4 AZAA 
 
 
 
 
 
 
 
Figure 3.12 AZAA MS/MS Spectrum 30% CID 
 The fragmentation spectrum for AZAA (M+H = 318) shows a base peak of b4 ion 
formation at a m/z of 300. This b4 ion is likely very stable due to its high relative abundance. 
There is no indication of b4 losing NH3 or H2O in significant amounts. The only other major peak 
on this spectrum is the b3 ion at a m/z of 229. There is some indication of b3 + H2O formation at 
an m/z of 247, but this peak is isobaric with AZAA y2 ion. There is no significant evidence for 
macrocyclization in AZAA. AZAA required approximately 32% CID to fragment to 50 percent 
of parent ion count, which is the lowest of the AXAA tetrapeptides (see Table 3.1). The 
energetics of AZAA could be further studied with computational studies to elucidate why so few 
fragments are formed.  
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3.4 X-Alanine-Alanine-Alanine  
3.4.1 KAAA 
 
 
 
 
 
 
 
 
Figure 3.13 KAAA MS/MS Spectrum 30% CID 
 The fragmentation spectrum for KAAA (M+H = 360) shows a base peak at a m/z of 129. 
This peak is most likely the formation of a b1 ion via lysine side chain attack of the adjacent C-
terminal carbonyl to form a 7 membered caprolactam derivative b ion (a lysine effect). There is 
evidence of loss of NH3 directly from the parent ion to form a peak at a m/z of 342. The b4 ion at 
a m/z of 343 can lose NH3 or H2O to form b4 –NH3 at 325 or b4- H2O at 324. Similarly, the b3 
and b2 peaks and lose NH3 or H2O. There is no significant presence of subsequent loss of NH3 
from the b4- H2O peak (or other b ion peaks). There is significant evidence of the formation of a 
b3 + H2O ion at a m/z of 289. This agrees with the results of Hiserodt et al. which found that N-
56 
 
terminus basic amino acid residues allow for the formation of b + H2O ions [56]. There is 
formation of an a2- NH3 ion, which is mainly observed for the AXAA and AAAX tetrapeptides. 
Finally, there is a significant intensity of AA dimer internal fragment formation. This dimer 
formation is noticed in significant quantities when the lysine residue is at the N or C terminus 
(KAAA or AAAK).  
 KAAA is likely not undergoing macrocyclization to create scrambled sequence product 
ion fragments. There are fragments observed that could represent a scrambled ion, but they all 
have potential explanations within KAAA fragmentation. For example, the low intensity peak at 
a m/z of 214 could represent the b3 of AAAK, but it is more likely to be a y3 – H2O peak. 
Additionally, the peak at m/z of 115 theoretically can only be explained as the a2 of AAKA or 
AAAK, but it is more likely to be a loss of 28 (CO) from the AA dimer at m/z of 143.   
 KAAA fragmentation resulted in the most number of product ion fragments of any of the 
XAAA tetrapeptides. KAAA required approximately 37% CID to fragment to 50 percent of 
parent ion count, which is the most %CID for the KAAA peptides (see Table 3.1). 
Computational studies to better understand the energetics of KAAA could elucidate why certain 
fragments are formed at higher intensities than others.  
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3.4.2 OAAA 
 
 
 
 
 
 
 
Figure 3.14 OAAA MS/MS Spectrum 30% CID 
 Fragmentation of OAAA (M+H = 346) results in a base peak at a m/z of 232 which is the 
y3 ion. This is an interesting result as fragmentation of OAAA would be expected to have a b1 
peak as the most abundant due to the ornithine effect. It seems that C-terminal cleavage after the 
ornithine residue is occurring in OAAA; however the proton is preferentially transferring to y 
fragment to form a y3 ion instead of a b1 ion. The study by McGee and McLuckey in 2013 which 
first described the ornithine effect only briefly mentioned that N-terminal ornithine effects 
mechanistically occur in the same manner as internal ornithine effects, and did not expand upon 
what occurs in fragmentation of peptides with ornithine at the N-terminus [47].  From this 
fragmentation spectrum of OAAA it is clear that there is an alternative mechanism or energetic 
preference at work for the ornithine effect.  
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 There is a small amount of b4 formation at a m/z of 328, which can lose NH3 to form a 
peak at a m/z of 311, but in tiny amounts. There is a significant abundance of the AA dimer at a 
m/z of 143. This is likely because there is already C-terminal cleavage to the ornithine residue 
that is energetically favored, and the AA dimer can more easily be formed. There is no 
significant evidence of macrocyclization in OAAA. OAAA required 31% CID to fragment to 50 
percent of parent ion count, which was the least of all XAAA tetrapeptides (see Table 3.1). This 
may be due to the energetic preference for C-terminal cleavage next to the ornithine residue. To 
further explore the energetics of OAAA, computational studies will be conducted.  
 
3.4.3 BAAA 
 
 
 
 
 
 
 
Figure 3.15 BAAA MS/MS Spectrum 30% CID 
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 The fragmentation spectrum for BAAA (M+ H = 332) results in a base peak at a m/z of 
232 which corresponds to a y3 ion. There is a significant formation of b4 ions at an m/z of 314, 
but loss of NH3 or H2O from the b4 ion is not observed. There is no major evidence of  b + H2O 
formation for BAAA. There is a strong peak at a m/z of 143 that could represent an AA dimer 
internal fragment of a y2- H2O product ion. Both could lose CO (28) to form the secondary 
fragment (AA-28) observed at a m/z of 115. There is no significant evidence of macrocyclization 
for BAAA. BAAA required 35% CID to fragment to 50 percent of parent ion count, which is 
greater than that of OAAA and BAAA (see Table 3.1). The energetics of BAAA will be further 
assessed using computational studies. 
3.4.4 ZAAA 
 
 
 
 
 
 
 
Figure 3.16 ZAAA MS/MS Spectrum 30% CID 
 The fragmentation spectrum for ZAAA (M+H = 318) results in a base peak at a m/z of 
300, which corresponds to the b4 ion. This b4 ion does not lose H2O or NH3 in any significant 
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amount. Interestingly, a ion formation is more abundant than y ion formation for ZAAA. The a2 
ion at a m/z of 229 can lose H2O to form a peak at a m/z of 211. This is the only instance of a – 
H2O ion formation in all of the tetrapeptides studied. There is no significant evidence of 
macrocyclization for ZAAA. ZAAA required 33% CID to fragment to 50 percent of parent ion 
count, which is greater than that of OAAA, but less than that of KAAA and BAAA (see Table 
3.1). ZAAA could be further assessed using computational studies to gain insight into the 
energetics and mechanisms of preferential a ion formation, and a2 – H2O ion formation.  
 
3.5 Tyrosine-Alanine-Glycine-X 
 As was discussed in sections 3.1 through 3.4 above, macrocyclization does not seem to 
occur in any significant amounts for the 16 AAAX, AAXA, AXAA, and XAAA tetrapeptides. It 
is difficult to tell if macrocyclization is occurring in these 16 peptides because three of the same 
amino acid residues (alanine) were used. This created isobaric ions that could otherwise have 
differentiated a normal fragment from a scrambled fragment (especially difficult when ions with 
loss and addition of H2O are formed). The YAGX set of tetrapeptides were synthesized and 
studied to look for macrocyclization in tetrapeptides because they contain four different amino 
acids, and resemble the pentapeptides (YAGFL- NH2) used by Harrison et al. to discover 
sequence scrambling after CID [48]. Therefore there are more potential fragment ions at masses 
diagnostic of sequence scrambling than the previous 16 tetrapeptides. Additionally, spectral 
analysis of the YAGX tetrapeptides was conducted to look for similar trends to those found for 
the set of AAAX tetrapeptides. 
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3.5.1 YAGK 
 
 
 
 
 
 
 
 
Figure 3.17 YAGK MS/MS Spectrum 30% CID 
 The fragmentation spectra of YAGK (M+H = 438) shows a base peak at a m/z of 204, 
which corresponds to the y2 ion. There is significant formation of a b4 ion at a m/z of 420, which 
can lose NH3 or H2O to form peaks at a m/z of 403 and 402, respectively.  There is a strong 
abundance of the b3 + H2O peak at a m/z of 310, which is further evidence that b + H2O ions can 
form with the lysine residue at the C-terminus of the peptide. From the base peak y2 ion, there is 
evidence of loss of H2O to form a peak at a m/z of 186, and subsequent loss of NH3 to form a 
peak at a m/z of 169. There is also a significant presence of an AG internal fragment dimer at a 
m/z of 129.  
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 Macrocyclization is occurring for YAGK, but in amounts that are not abundant enough to 
affect peptide sequencing and searching databases. For example, there is a very low intensity 
peak at a m/z of 367, which is the y3 of the tetrapeptide AGKY. This indicates macrocyclization 
is occurring, but in very small amounts. Additionally, the peak at a m/z of 186 could be a y2 – 
H2O ion, or it could be the sequence scrambled b2 ion of GKYA.  
 YAGK required approximately 47% CID to fragment to 50 percent of initial parent ion 
count (see Table 3.2). The YAGK spectrum shows a significantly larger number of fragments 
than the YAGO, YAGB and YAGZ spectra. Assessing the energetics of YAGK via 
computational studies may be beneficial for better characterizing the fragmentation patterns of 
YAGK.  
Tetrapeptide %CID 
YAGK 47 
YAGO 33 
YAGB 31 
YAGZ 33 
 
Table 3.2 Approximate % CID required to fragment each peptide to 50 percent of parent ion 
count for YAGX tetrapeptides (see Appendix for graphs). 
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3.5.2 YAGO 
 
 
 
 
 
 
 
 
Figure 3.18 YAGO MS/MS Spectrum 30% CID 
 The fragmentation spectrum of YAGO (M+H = 424) show the base peak at a m/z of 406, 
which corresponds to the b4 ion. This b4 ion is formed as a result of the ornithine effect, and 
therefore is the base peak as expected. The b4 peak can lose H2O or NH3 to form peaks at a m/z 
of 388 and 389, respectively. The b4 – H2O can then subsequently lose NH3 to form a peak at a 
m/z of 371 (as was seen in AAAO), but this occurs at a very small intensity. There is evidence of 
a b3 + H2O peak at a m/z of 310. This is further evidence that ornithine is a basic enough residue 
to cause the formation of b + H2O ions, and that b + H2O ion formation can occur with the basic 
residue at the C-terminus (not just the N terminus as found in [56]). There is no a ion formation 
in the fragmentation of YAGO.  
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 Macrocyclization is likely not occurring for YAGO. However, the b3 + H3O peak at a m/z 
of 310 could also be the sequence scrambled y3 ion of OYAG. YAGO required approximately 
33% CID to fragment to 50 percent of initial parent ion count (see Table 3.2). Interestingly, 
YAGO required a similar amount of %CID as that of YAGB and YAGZ. The YAGO spectrum 
show very few fragments, especially as compared to YAGK. Assessing the energetics of YAGO 
via computational studies may be beneficial for better characterizing the fragmentation patterns 
of YAGO. 
3.5.3 YAGB 
 
 
 
 
 
 
 
 
Figure 3.19 YAGB MS/MS Spectrum 30% CID 
 The fragmentation spectrum for YAGB (M+H = 410) shows a b4 base peak at a m/z of 
392, potentially indicative of a DABA effect. This high relative abundance b4 ion is also 
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observed for YAGO and YAGZ (and AAAO, AAAB, AAAZ). There is evidence of b4 losing 
H2O form a peak at a m/z of 374. No an ions are observed in this fragmentation spectrum. There 
is potentially evidence of a b3 + H2O ion at a m/z of 310, but it is isobaric with the y3 ion. 
Macrocyclization is likely not occurring for YAGB. YAGB required approximately 31% CID to 
fragment to 50 percent of initial parent ion count (see Table 3.2). Again, YAGB required a 
similar % CID as that if YAGO and YAGZ. The YAGB spectrum show very few fragments, 
especially as compared to YAGK. Assessing the energetics of YAGB via computational studies 
may be beneficial for better characterizing the fragmentation patterns of YAGB. 
3.5.4 YAGZ 
 
 
 
 
 
 
 
Figure 3.20 YAGZ MS/MS Spectrum 30% CID 
 The fragmentation spectrum for YAGZ (M+H = 396) shows a b4 ion base peak at a m/z 
of 378, which was also observed for YAGO and YAGB.  There is evidence of b4 losing H2O or 
NH3 to form peaks at a m/z of 360 and 359, respectively. No an ions are observed in this 
66 
 
fragmentation spectrum. There is evidence of a b3 + H2O ion at a m/z of 310, but it is formed at 
a very low relative abundance. Macrocyclization is likely not occurring for YAGZ. YAGZ 
required approximately 33% CID to fragment to 50 percent of initial parent ion count (see Table 
3.2). Again, YAGZ required a similar % CID as that if YAGO and YAGB. The YAGZ spectrum 
show very few fragments, especially as compared to YAGK. Assessing the energetics of YAGZ 
via computational studies may be beneficial for better characterizing the fragmentation patterns 
of YAGZ. 
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3.6 Trends 
 In general, little or no macrocyclization leading to sequence scrambling is occurring for 
the 20 tetrapeptides studied. The AAAX, AAXA, AXAA, and XAAA tetrapeptides were not the 
most effective choice for studying sequence scrambling because of the large number of isobaric 
ions possible in the fragmentation spectra, especially when considering the  yn + H2O, yn – H2O, 
bn + H2O, and bn – H2O ions formed. Macrocyclization and sequence scrambling was observed 
in YAGK (via formation of the y3 ion of AGKY). However, the intensity of the AGKY y3 peak 
is too low for it to be a significant detriment to peptide searching and sequencing algorithms.  
 There were interesting trends based on lysine or lysine analog positional variance within 
the tetrapeptides, and based on the differing basicities of lysine and its analogs. The AAAO and 
YAGO tetrapeptides showed a prevalence of (bn –H2O) - NH3 ion formation, whereas the other 
18 tetrapeptides did not. DABA and DAPA containing tetrapeptides had minimal b4-NH3 
formation as compared to lysine and ornithine containing tetrapeptides. The lower basicities or 
shorter side chain lengths of DABA and DAPA as compared to lysine or ornithine influences the 
absence of losses from bn ions. Additionally, an ions were the least prevalent for the AAXA and 
XAAA tetrapeptides. The AXAA and AAAX tetrapeptides all showed a2-NH3 ion formation 
while only KAAA of the XAAA set and none of the AAXA tetrapeptides showed a2 – NH3 
formation.  
 For dipeptides, bn + H2O formation is favored when a basic amino acid residue is on the 
N-terminus [56]. For the tetrapeptides studied, only KAAA of the XAAA set shows bn + H2O 
formation. The AAAK AAAO, YAGK, and YAGO tetrapeptides show the formation of bn + 
H2O formation when fragmented, whereas the others do not. This indicates that bn + H2O ion 
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formation may also be preferential when the basic residue is at the C-terminus in tetrapeptides. In 
addition to positional variance, the lack of bn + H2O formation for OAAA, BAAA, ZAAA, 
AAAB, and AAAZ shows that the basicity of the amino acid residue plays a role (less likely to 
occur with lower basicity residue). There is intense K and O monomer formation for AAKA, 
AKAA, AAOA, and AOAA, but minimal or no monomer formation for DABA and DAPA 
containing tetrapeptides. The mechanism of fragmentation to form these monomers is likely 
dictated by the length of the amino acid side chain, and/or the basicity of the amino acid residues 
(DABA and DAPA are shorter and less basic than lysine and ornithine).  
 Based on number of peaks and CID data (see Table 3.1), it is apparent that positional 
variance of lysine and its NPAA analogs affects the stabilities of the AAAX, AAXA, AXAA and 
XAAA tetrapeptides. For example, AAAB required the most % CID to fragment to 50 percent of 
parent ion count of the AAAX tetrapeptides. This indicates that the intramolecular stabilization 
via hydrogen bonding between the DABA side chain and oxygen or nitrogen atoms in the 
peptide backbone is stronger than that of lysine, ornithine, or DAPA (for AAAX). This is likely 
due to DABA having an optimal side chain length for hydrogen bonding when the X residue is at 
the C-terminus.   
 Finally, the presence of the ornithine effect was confirmed in all ornithine containing 
tetrapeptides. There is some evidence to suggest a lysine effect, which causes preferential C-
terminal cleavage, exists (see AAKA, AKAA, and KAAA) but it is not as marked as the 
ornithine preferential cleavage. Additionally, ABAA fragmentation shows an abundant b2 
product ion peak, potentially indicating that DABA can cause preferential C-terminal cleavage 
under certain conditions.  
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Chapter 4: Conclusions 
 This project used ESI- ion trap mass spectrometry with CID to fragment the lysine and 
lysine analog containing tetrapeptides AAAX, AAXA, AXAA, XAAA and YAGX (X = Lys, 
Orn, DABA, or DAPA). Results show that no macrocyclization leading to sequence scrambling 
occurs in significant amounts for these tetrapeptides. However, it was difficult to discern if 
macrocyclization is occurring in the AAAX, AAXA, AXAA, and XAAA tetrapeptides due to 
isobaric fragment ions between original and scrambled tetrapeptides. The presence of 
macrocyclic sequence scrambling in YAGK at a very small abundance, but not in YAGO, 
YAGB, or YAGZ may indicate that sequence scrambling is possible, but not energetically 
favorable for tetrapeptide fragmentation using CID.  
 The fragmentation studies did find significant trends in fragmentation patterns of the 20 
tetrapeptides based on positional variance and/or basicities of the lysine, ornithine, DABA, and 
DAPA residues. The formation of bn + H2O ions when basic amino acid residues are at the C-
terminus is possible in tetrapeptides (as opposed to findings for dipeptides [56]). Monomer 
fragment formation was observed for lysine and ornithine containing tetrapeptides at a 
significantly higher relative abundance than in DABA and DAPA containing tetrapeptides, due 
to the smaller side chain length and/or lower basicity of DABA and DAPA as compared to lysine 
and ornithine. The DABA and DAPA containing tetrapeptides had minimal b4-NH3 formation as 
compared to lysine and ornithine containing tetrapeptides. The ornithine effect was confirmed, 
and a possible lysine effect and DABA effect were observed. Additionally, the CID activation 
scan data shows differences in the stabilities of the tetrapeptides based on the amino acid residue 
present.   
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 Future work will involve the synthesis and fragmentation of YAXG, YXAG, and XYAG 
tetrapeptides to look for macrocyclization and positional variance effects on fragmentation 
patterns. Additionally, density functional theory computational calculations will be conducted to 
assess the thermodynamics of the 20 tetrapeptides discussed in this thesis, and the 12 new 
tetrapeptides. Hydrogen deuterium exchange (HDX) will be performed on these tetrapeptides to 
explore hydrogen bonding between the amino acid side chains and the peptide backbones, 
leading to more information on the stabilities of the tetrapeptides. Techniques such as infrared 
multiphoton dissociation (IRMPD) will be employed to determine how positional variance 
and/or basicities of lysine, ornithine, DABA, and DAPA can affect the structure of the bn ions 
formed.  
 Studying the fragmentation patterns of larger lysine and lysine analog containing peptides 
will provide more insight into the mechanisms of ion formation at play. Analyzing the 
fragmentation mechanisms of peptides that are 9 or 10 amino acids long which contain lysine or 
arginine at the C-terminus are particularly relevant to tryptic digests and bottom-up proteomics 
research. Finally, it will be beneficial to look at doubly protonated lysine species fragmentation 
studies, and expand research to arginine containing peptides to discern fragmentation 
mechanisms and ensure a robust proteomics experiment.  
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Appendix 
 
Below are the graphs of the CID activation parameter scans for AAAX, AAXA, AXAA, 
XAAA, and YAGX:  
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